Unbiased RNA sequencing could provide a more comprehensive view of TARDBP knockdown effects and also uncover important differences between the shRNA knockdown model and the ALS patient-derived MDMi model. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.